Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Oxford Biomedica Plc (OP: OXBDF ) 5.100 UNCHANGED Streaming Delayed Price Updated: 2:09 PM EST, Nov 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Oxford Biomedica Plc The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact July 01, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Benzinga Before The Bell: Kohl's Deal Talks Cancellation, Tesla's Racial Discrimination Lawsuit, Nio's Strong June Deliveries And Other Top Financial Stories Friday, July 1 July 01, 2022 CNBC Why Kohl’s Shares Are Plunging Today Via Benzinga Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccine July 01, 2022 Via Benzinga The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program February 01, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Oxford Biomedica, Homology Medicines Enter Deal To Expand Viral Vector Offerings January 28, 2022 London-listed cell and gene therapy Oxford Biomedica Plc (OTC: OXBDF) said it would form a viral vector manufacturing business with Homology Medicines Inc (NASDAQ: FIXX). Via Benzinga Oxford BioMedica To Manufacture More Doses Of AstraZeneca's COVID-19 Vaccine, Upgrades 2021 Outlook May 18, 2021 Oxford BioMedica Plc (OTC: OXBDF) has raised its forecast for cumulative revenues from AstraZeneca Plc (NASDAQ: AZN) by the end of 2021 to more than... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO May 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... Via Benzinga Exposures COVID-19 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
